FDA approves P&F’s transcatheter bicaval valve system trial

US FDA clears pivotal trial for bicaval valve system for TR

Interventional structural cardiologists at Tampa General Hospital (TGH) and USF Health completing a procedure under the FDA early feasibility study pathway for the TricValve system P&F USA, the US subsidiary of heart valve manufacturer P&F Products and Features, has announced that the US Food and Drug Administration (FDA) has approved initiation of the TRICAV II pivotal trial. The study will evaluate the TricValve transcatheter bicaval valve sys…

FDA approves P&F’s transcatheter bicaval valve system trial

The FDA has granted approval for P&F USA to begin the TRICAV II pivotal trial of the TricValve transcatheter bicaval valve system.The post FDA approves P&F’s transcatheter bicaval valve system trial appeared first on Medical Device Network.